Oliver Tracie 4
4 · ARROWHEAD PHARMACEUTICALS, INC. · Filed Jul 3, 2024
Insider Transaction Report
Form 4
Oliver Tracie
Chief Commercial Officer
Transactions
- Sale
Common Stock
2024-07-02$25.28/sh−9,394$237,480→ 127,107 total
Footnotes (3)
- [F1]Shares were sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
- [F2]Partial disposition of RSUs to satisfy tax withholding obligations.
- [F3]Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions.